50 min
286 – Identifying Rare Compounds with A.I. Talking Biotech Podcast
-
- Life Sciences
Tweet
While genomics approaches have opened a universe of new compounds in plants, the vast majority remain uncharacterized. Brightseed has employed an artificial intelligence platform to scan for novel compounds, with a goal to identify new chemicals that may play a role in human health. Today’s podcast features Dr. Jim Flatt, CEO and Co-Founder of Brightseed. He discusses the company’s pilot products and the pipeline of compounds that may enhance human health.
www.brightseedbio.com
Tweet
While genomics approaches have opened a universe of new compounds in plants, the vast majority remain uncharacterized. Brightseed has employed an artificial intelligence platform to scan for novel compounds, with a goal to identify new chemicals that may play a role in human health. Today’s podcast features Dr. Jim Flatt, CEO and Co-Founder of Brightseed. He discusses the company’s pilot products and the pipeline of compounds that may enhance human health.
www.brightseedbio.com
50 min